Clinical trials examining rituximab maintenance therapy. The induction phase has included the use of chemotherapy alone, rituximab alone, or chemoimmunotherapy. The PRIMA and MAXIMA studies are ongoing randomized studies examining the use of chemoimmunotherapy followed by rituximab maintenance.